Delivering end-to-end supply chain strategy and transformation
As we’ve seen with the global pandemic, biopharma’s supply chains and operations are vital and yet so tested managing these unparalleled challenges..
Now is the time for decisive leadership across the biopharma value chain to ensure supply of life-saving therapies and vaccines. Life sciences leaders are changing long-held paradigms to emerge stronger and more resilient.
According to our research, 60% of supply chain executives (pharma/biopharma/medical device) struggle to get real-time inventory and visibility from external manufacturing partners. And yet, nearly all of them plan to expand their use of contract manufacturers in the next three years. This growth and increased complexity in life sciences supply chains requires an entirely different approach to collaboration to meet the demands of New Science and personalized treatments and devices.
In this report we bring to light the similarities and differences in the challenges both parties face and share real-world examples of where digital technology can help solve collaboration pain points. The report features companies who are getting it right and four key steps to establish a new level of supply chain collaboration.
READ THE REPORTOur supply chain & operations capabilities are designed to help clients achieve visibility and act with agility now to become a more responsive and resilient organization.
A patient-centric supply chain requires that biopharma companies go beyond digitizing their supply chain and put patients at the center of operations.
As New Science grows in prominence, a new economic environment is demanding change for biopharma’s.
filter result
Managing Director – Life Sciences, Global Supply Chain and Industry X
Managing Director – Strategy & Consulting, Supply Chain & Operations, Customer-Centric Supply Chain Lead
